USPTO 2015–2025 USPTO PatentsView US Corporation

Corbion Biotech, Inc.

USPTO PatentsView assignee record - 40 granted patents across 33 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

15.9

Avg claims per patent

-26%

5-year filing velocity

The verdict

Corbion holds 40 US patents across 33 technology areas, rank #8,003 of 50,000 tracked assignees.

#8,003
of 50,000 US assignees by volume: Top 23%
by Innovation Score (45.3/100): 15.9
avg claims per patent: -26%
filing velocity, last 5 yrs

Portfolio overview

Corbion Biotech, Inc. has been granted 40 US utility patents between 2018 and 2025, placing Corbion Biotech, Inc. at rank #8,003 across all assignees tracked by PlainPatent. This portfolio spans 33 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.9 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Corbion Biotech, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Corbion sits between Centre Of Excellence In Wireless Technology (40 patents, rank #7,999) and Darfon Electronics (suzhou) Co., Ltd. (40 patents, rank #8,007) - the closest US assignees by grant volume. The composite Innovation Score of 45.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 17 grants, compared with 23 in the 2015–2019 window, a -26% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Corbion Biotech, Inc.'s 15.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 33 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Corbion Biotech, Inc. against peers pursuing similar technology classes.

Centre of Excelle…

40
Cephalon

40
Cloudminds Roboti…

40
Club Car

40
Coriant Operations

40
Credence Medsyste…

40
Danfoss Power Sol…

40
Darfon (Suzhou)

40
Corbion Biotech ◀

40

What this shows Corbion holds 40 patents at rank #8,003, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Corbion

By rank, the assignees closest to #8,003 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Corbion's primary technology class.

Corbion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Corbion Biotech, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	10	25.0%
2019	13	32.5%
2020	5	12.5%
2021	2	5.0%
2022	4	10.0%
2023	3	7.5%
2024	1	2.5%
2025	2	5.0%

Which technologies does Corbion Biotech, Inc. patent most?

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 28

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 24

C12Y - ENZYMES 18

C11B - PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES 9

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 9

Y02E - REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION 8

A23D - EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS 8

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 7

A23K - FODDER 6

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 6

C11C - FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM 5

C12R - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS 5

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 5

C07K - PEPTIDES 4

C07J - STEROIDS 4

Top 15 of 33 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#8,003

Across all tracked assignees

Innovation Score

45.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Corbion Biotech, Inc. hold?

Corbion Biotech, Inc. holds 40 US granted patents filed between 2018 and 2025, spanning 33 technology areas.

What is Corbion Biotech, Inc.'s Innovation Score?

Corbion Biotech, Inc. has an Innovation Score of 45.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Corbion Biotech, Inc. focus on?

Corbion Biotech, Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 28 patents. The company has filed patents in 33 CPC subclasses total.

Is Corbion Biotech, Inc.'s patent filing rate increasing or decreasing?

Corbion Biotech, Inc.'s recent filing velocity is -26% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Corbion Biotech, Inc.'s patents?

Corbion Biotech, Inc.'s patents average 15.9 claims each. This falls within the standard range, providing solid legal coverage.

How is the Corbion Biotech, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Corbion's 40 grants land it in the top 23% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Corbion ranks #8,003 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.